Cognes

Cognes is developing a scalable, self-administered & non-invasive dementia screening method through a smartphone app utilizing machine-learning technology. Our SaaS medical device company offers an innovative early detection dementia screening solution tailored specifically for the healthcare industry. With our cutting-edge technology, we empower healthcare professionals and researchers to identify individuals at risk of developing dementia at an early stage, enabling timely interventions and more effective treatment strategies. Our goal is to enable early detection of dementia for anyone, anywhere.